CA
NZ
UK
AU
IND
US
…
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on AirSculpt Technologies Inc is limited, so its core operations and revenue mix are not well documented. If it operates in aesthetic medical technology or clinic services, long-term growth drivers may include rising elective-procedure demand and adoption of minimally invasive techniques; investors may find the company attractive if it shows scalable unit economics and repeat-procedure demand.
Key risks are limited disclosure, regulatory approval uncertainty and execution or financial strain.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -17.64M | -8.06M | 3.00M | -11.30M | 10.88M |
| Net income | -11.67M | -8.25M | -4.48M | -14.68M | 10.55M |
| Selling general administrative | 82.18M | 72.18M | 82.38M | 101.42M | 65.73M |
| Selling and marketing expenses | - | 33.40M | 25.90M | - | - |
| Gross profit | 90.13M | 108.97M | 121.91M | 106.01M | 88.78M |
| Reconciled depreciation | 12.78M | 11.89M | 9.70M | 8.06M | 6.60M |
| Ebit | -11.56M | -1.82M | 9.48M | -3.47M | 15.77M |
| Ebitda | 1.22M | 10.07M | 19.74M | 4.59M | 23.05M |
| Depreciation and amortization | 12.78M | 11.89M | 10.25M | 8.06M | 7.28M |
| Operating income | -4.83M | -1.82M | 9.48M | -3.47M | 15.77M |
| Other operating expenses | 156.65M | 182.17M | 186.43M | 172.26M | 116.86M |
| Interest expense | 6.08M | 6.25M | 6.49M | 6.75M | 4.89M |
| Tax provision | -5.97M | 0.19M | 1.82M | 3.38M | 0.33M |
| Net interest income | -6.08M | -6.25M | -7.39M | -6.75M | -4.89M |
| Non recurring | - | - | - | 0.15M | - |
| Income tax expense | -5.97M | 0.19M | 7.48M | 3.38M | 0.33M |
| Total revenue | 151.82M | 180.35M | 195.92M | 168.79M | 133.31M |
| Total operating expenses | 94.96M | 110.78M | 112.42M | 109.48M | 72.33M |
| Cost of revenue | 61.69M | 71.38M | 74.01M | 62.78M | 44.54M |
| Total other income expense net | -12.80M | -6.25M | -6.49M | -7.83M | -4.89M |
| Net income from continuing ops | -11.67M | -8.25M | -7.10M | -14.68M | 10.55M |
| Net income applicable to common shares | - | - | - | -14.68M | 10.55M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 187.30M | 210.00M | 213.55M | 200.76M | 200.55M |
| Intangible assets | 36.84M | 41.59M | 46.35M | 51.10M | 55.85M |
| Other current assets | 5.51M | 5.83M | 3.76M | 4.23M | 4.09M |
| Total liab | 99.59M | 130.71M | 129.56M | 129.99M | 117.03M |
| Total stockholder equity | 87.71M | 79.29M | 83.99M | 70.77M | 83.53M |
| Deferred long term liab | - | - | - | 5.49M | 4.35M |
| Other current liab | 7.91M | 10.84M | 7.43M | 9.63M | 6.61M |
| Common stock | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M |
| Capital stock | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M |
| Retained earnings | -40.57M | -27.80M | -19.55M | -15.07M | -0.39M |
| Other liab | - | - | - | 6.51M | 18.86M |
| Good will | 81.73M | 81.73M | 81.73M | 81.73M | 81.73M |
| Other assets | - | - | 0.00M | 3.28M | 171.11M |
| Cash | 8.45M | 8.23M | 10.26M | 9.62M | 25.35M |
| Total current liabilities | 27.90M | 28.61M | 20.32M | 22.32M | 16.41M |
| Current deferred revenue | 1.87M | 1.17M | 1.46M | 2.36M | 2.81M |
| Net debt | 75.12M | 96.82M | 89.41M | 98.03M | 75.24M |
| Short term debt | 12.76M | 10.35M | 7.50M | 6.48M | 4.32M |
| Short long term debt | 5.46M | 4.25M | 2.12M | 2.12M | 0.85M |
| Short long term debt total | 83.57M | 105.05M | 99.67M | 107.65M | 100.58M |
| Other stockholder equity | 128.31M | 107.72M | 103.90M | 85.86M | 83.86M |
| Property plant equipment | - | - | - | 24.21M | 13.63M |
| Total current assets | 15.46M | 17.12M | 15.96M | 16.68M | 29.44M |
| Net tangible assets | - | - | - | 70.77M | 83.53M |
| Net receivables | 1.50M | 3.06M | 1.94M | 2.83M | 1.74M |
| Long term debt | 50.59M | 70.46M | 69.50M | 81.42M | 81.75M |
| Accounts payable | 5.37M | 6.26M | 3.92M | 3.84M | 2.67M |
| Accumulated other comprehensive income | -0.10M | -0.69M | -0.41M | -0.08M | - |
| Common stock total equity | - | - | - | 0.06M | 0.06M |
| Retained earnings total equity | - | - | - | -15.07M | -0.39M |
| Non currrent assets other | 3.01M | 6.41M | 5.66M | 3.28M | 1.74M |
| Non current assets total | 171.85M | 192.88M | 197.59M | 184.08M | 171.11M |
| Capital lease obligations | 27.52M | 30.35M | 28.04M | 24.10M | 17.98M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -14.01M | -10.29M | -12.92M | -7.12M |
| Change to liabilities | - | - | - | 9.04M | 6.34M |
| Total cashflows from investing activities | -2.40M | -14.01M | -9.92M | -12.92M | -7.12M |
| Net borrowings | -18.79M | 2.88M | -12.12M | -0.76M | 48.77M |
| Total cash from financing activities | -0.48M | 0.63M | -13.39M | -27.26M | -4.55M |
| Change to operating activities | - | - | - | 0.89M | -0.38M |
| Net income | -11.67M | -8.25M | -4.48M | -14.68M | 10.55M |
| Change in cash | 0.21M | -2.03M | 0.65M | -15.73M | 14.97M |
| Begin period cash flow | 8.23M | 10.26M | 9.62M | 25.35M | 10.38M |
| End period cash flow | 8.45M | 8.23M | 10.26M | 9.62M | 25.35M |
| Total cash from operating activities | 3.10M | 11.35M | 23.96M | 24.45M | 26.63M |
| Issuance of capital stock | 18.76M | 0.00M | 0.00M | 0.00M | 13.54M |
| Depreciation | 12.78M | 11.89M | 10.25M | 8.06M | 6.60M |
| Dividends paid | 0.00M | 0.25M | 0.46M | 24.32M | 66.86M |
| Change to account receivables | 1.56M | -1.11M | 0.89M | - | - |
| Sale purchase of stock | - | -0.90M | -0.23M | - | 13.54M |
| Other cashflows from financing activities | -0.06M | -1.09M | -0.57M | 81.33M | 49.60M |
| Change to netincome | - | - | - | 31.67M | 8.07M |
| Capital expenditures | 2.40M | 14.01M | 9.92M | 12.92M | 7.12M |
| Cash flows other operating | - | - | - | -10.56M | -5.57M |
| Cash and cash equivalents changes | - | - | - | -15.73M | 14.97M |
| Change in working capital | -1.69M | 3.85M | -1.38M | -1.53M | 0.77M |
| Stock based compensation | 2.33M | 3.76M | 18.22M | 29.46M | 7.18M |
| Other non cash items | 7.25M | 0.35M | -0.01M | 2.00M | 1.32M |
| Free cash flow | 0.69M | -2.66M | 14.04M | 11.53M | 19.52M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AIRS Airsculpt Technologies Inc |
0.06 3.59% |
1.73 | - | - | 1.23 | 2.12 | 1.72 | 214.06 |
| HCA HCA Healthcare, Inc. |
-4.89 1.02% |
473.19 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
2.68 0.99% |
273.25 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.31 2.36% |
13.35 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.09 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
| Name | Title | Year Born |
|---|---|---|
| Dr. Aaron J. Rollins M.D. | Founder, CEO & Director | 1976 |
| Mr. Ronald Paul Zelhof | COO & Pres | 1964 |
| Mr. Dennis Dean | Chief Financial Officer | 1972 |
| Ms. Liraz Isaac | Head of People | NA |
| Dr. Aaron J. Rollins M.D. | Founder & Executive Chairman | 1976 |
| Mr. Todd Magazine | CEO, President & Director | 1964 |
| Stephanie Evans Greene | Chief Marketing Officer | NA |
| Mr. Yogesh Jashnani | CEO & Director | 1982 |
| Mr. Michael J. Arthur | Chief Financial Officer | 1988 |
| Mr. Brent R. Wadman J.D. | General Counsel | 1972 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...